Clinical Observation on 60 Cases of Chronic Pulmonary Heart Disease at Acute Attack Stage Treated with Fei Xin Ning Mixture Combined with Western Medicine Therapy

doi:10.13288/j.11-2166/r.2001.02.020

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on 60 Cases of Chronic Pulmonary Heart Disease at Acute Attack Stage Treated with Fei Xin Ning Mixture Combined with Western Medicine Therapy

更新时间：2021-11-20

- Clinical Observation on 60 Cases of Chronic Pulmonary Heart Disease at Acute Attack Stage Treated with Fei Xin Ning Mixture Combined with Western Medicine Therapy
- Journal of Traditional Chinese Medicine Issue 2, Pages: 89-91(2001)
- 作者机构：
  
  湖南省湘乡市中医院湘乡市昆仑桥,411400
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2001.02.020
  CLC： R541.5
- Published：2001
- 稿件说明：
移动端阅览
[1]周端球.肺心宁合剂配合西医疗法治疗慢性肺原性心脏病急性发作期60例临床观察[J].中医杂志,2001(02):89-91+68.

Clinical Observation on 60 Cases of Chronic Pulmonary Heart Disease at Acute Attack Stage Treated with Fei Xin Ning Mixture Combined with Western Medicine Therapy[J]. Journal of Traditional Chinese Medicine2001, (2): 89-91.
[1]周端球.肺心宁合剂配合西医疗法治疗慢性肺原性心脏病急性发作期60例临床观察[J].中医杂志,2001(02):89-91+68. DOI： 10.13288/j.11-2166/r.2001.02.020.

Clinical Observation on 60 Cases of Chronic Pulmonary Heart Disease at Acute Attack Stage Treated with Fei Xin Ning Mixture Combined with Western Medicine Therapy[J]. Journal of Traditional Chinese Medicine2001, (2): 89-91. DOI： 10.13288/j.11-2166/r.2001.02.020.

摘要

探讨肺心宁合剂对慢性肺原性心脏病（肺心病）急性发作期的治疗效果。治疗组60例患者和单纯西药治疗之对照组60例患者均以吸氧、解痉平喘、抗感染、纠正呼吸衰竭和心力衰竭为基础治疗。治疗组加用自制中药肺心宁合剂治疗。2组皆以15天为1个疗程

并于治疗前后检测血浆内皮素-1（ET—1）水平和血液流变学变化。结果:治疗组显效率73.33％

总有效率93.34％;对照组显效率35％

总有效率68.34％

2组总有效率比较差异有显著性（P<0.01）。血浆ET—1水平治疗组治疗后为（69.8±15.8）ng/L

显著低于对照组（78.1±13.5）ng/L（P<0.01）

治疗组治疗后血液流变学指标较治疗前及对照组治疗后明显下降（P<0.05或P<0.01）。提示肺心宁合剂对慢性肺心病急性发作期患者可明显提高总有效率

能降低血浆ET—1水平和改善血液流变学。疗效明显优于单纯西药治疗组。

Abstract

Sixty cases of chronic pulmonary heart disease at acute attack stage in the treatment group and 60 cases of the control group were treated with oxygen - inspiration

relieving spasm and asthma

anti - infection

and correcting respiratory failure and heart failure as basic treatment. Self - made Chinese drug Fei Xin Ning Mixture was added to the treatment group. In the two groups. 15 days constituted one course. Plasma endothelin 1 （ET-1） level and hernorheologic indices were determined before and after treatment. Results indicated that the markedly effective rate

effectice rate and the total effective rate in the treatment group were 73. 33%. 20% and 93. 34% respectively

and 35%

33. 34% and 68. 34% in the control group

with significant difference in the total effective rate between the two groups <P<.0. 01). Plasma endothelin -1 level after treatment in the treatment group was significantly lower than that in the control group （P <0. 01）

and the hetnorheologie indices in the treatment group decreased significantly as compared with those before treatment or after treatment in the control group （P<0. 05 or P<0. 01）. It is suggested that Fei Xin Ning Mixture can obviously increase the total effective rate and decrease plasma endothelin - 1 level and improve blood rheology for chronic pulmonary heart disease at acute attack stage

and it has a better therapeutic effect than that of the simple Western medicine treatment.

关键词

Keywords

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Tongbian Decoction （通便汤） on the VAPB-PTPIP51 Complex and Autophagy of Interstitial Cells of Cajal in the Colon of Slow Transit Constipation Model Rats

Similarities and Differences between Myofascial Trigger Points and Sinew Knot：from the Perspective of the Channel Sinew Theory

Syndrome Differentiation and Treatment of Cholinergic Urticaria from the Perspective of "Treating Fire Constraint by Dispersing It"

Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"

Current Status and Strategic Recommendations for Randomized Controlled Trials on Functional Dyspepsia-Irritable Bowel Syndrome Comorbidity：from a Real-World Research Perspective

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰